Signalling through phosphoinositide 3-kinases: The lipids take centre stage

Current Opinion in Cell Biology

Volumn 11, Issue 2, 1999, Pages 219-225

  Leevers, Sally J ^a   Vanhaesebroeck, Bart ^b   Waterfield, Michael D ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE; INOSITOL; LIPID; PHOSPHATE; PHOSPHATIDYLINOSITIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PLECKSTRIN; PROTEIN TYROSINE KINASE;

PHOSPHORYLATION; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

EID: 0032929762     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-0674(99)80029-5     Document Type: Article

References (54)

1. Vanhaesebroeck B., Leevers S.J., Panayotou G., Waterfield M.D. Phosphoinositide 3-kinases: a conserved family of signal transducers. Trends Biochem Sci. 22:1997;267-272.
2. 3] and its stereoisomers. Bioorg Med Chem Lett. 7:1997;3171-3176.
3. Hinchcliffe K., Irvine R. Inositol lipids pathways turn turtle. Nature. 390:1997;123-124.
4. Cooke F.T., Dove S.K., McEwen R.K., Painter G., Holmes A.B., Hall M.N., Michell R.H., Parker P.J. The stress-activated phosphatidylinositol 3-phosphate 5-kinase Fab1p is essential for vacuole function in S. cerevisiae. Curr Biol. 8:1998;1219-1222.
5. Gary J.D., Wurmser A.E., Bonangelino C.J., Weisman L.S., Emr S.D. Fab1p is essential for PtdIns(3)P 5-kinase activity and the maintenance of vacuolar size and membrane homeostasis. J Cell Biol. 143:1998;65-79.
6. Corvera S., Czech M.P. Direct targets of phosphoinositide 3-kinase products in membrane traffic and signal transduction. Trends Cell Biol. 8:1998;442-446.
7. Wiedemann C., Cockcroft S. Sticky fingers grab a lipid. Nature. 394:1998;426-427.
8. Stenmark H., Aasland R., Toh B.H., D'Arrigo A. Endosomal localization of the autoantigen EEA1 is mediated by a zinc-binding FYVE finger. J Biol Chem. 271:1996;24048-24054.
9. Patki V., Virbasius J., Lane W.S., Toh B.H., Shpetner H.S., Corvera S. Identification of an early endosomal protein regulated by phosphatidylinositol 3-kinase. Proc Natl Acad Sci USA. 94:1997;7326-7330.
10. 3.
11. 2.
12. Burd C.G., Emr S.D. Phosphatidylinositol(3)-phosphate signaling mediated by specific binding to RING FYVE domains. Mol Cell. 2:1998;157-162. In this paper, GFP-FYVE domain fusion proteins are shown to localise to pre-vacuolar endosomes of living yeast cells but not if the gene encoding the class III PI3K, Vps34p, is mutated. The importance of the predicted amphipathic helix immediately amino-terminal of the EEA1 FYVE domain for endosomal location is also noted. This is the region through which EEA1 interacts with Rab5. In addition, the FYVE domains of EEA1, Vac1p, Vps27p, Fab1p and Pib1 are all shown to bind to PI(3)P-containing liposomes in vitro.
13. Simonsen A., Lippe R., Christoforidis S., Gaullier J.M., Brech A., Callaghan J., Toh B.H., Murphy C., Zerial M., Stenmark H. EEA1 links PI(3)K function to Rab5 regulation of endosome fusion. Nature. 394:1998;494-498. This paper describes the identification of EEA1 as an effector for Rab5 and proposes that EEA1 needs to interact with both Rab5 and PI(3)P in the membrane of early endosomes for endosome fusion to occur. Overexpression of the Rab5- and PI(3)P-binding carboxyl terminus of EEA1 is shown to have an inhibitory effect and result in the formation of small endocytic structures. Expression of the same carboxy-terminal fragment of EEA1 also blocks the ability of Rab5 overexpression to induce the formation of expanded early endosomes.
14. Lemmon M.A., Falasca M., Ferguson K.M., Schlessinger J. Regulatory recruitment of signalling molecules to the cell membrane by pleckstrin-homology domains. Trends Cell Biol. 7:1997;237-242.
15. Downward J. Mechanisms and consequences of activation of protein kinase B/Akt. Curr Opin Cell Biol. 10:1998;262-267.
16. 3 - was most effective in these in vitro assays.
17. 3binds directly to the PH domain of Akt to facilitate phosphorylation of Thr308 and directly activates PDK1.
18. 3-dependent manner (again at a reduced rate). It was also reported that although PDK1 is phosphorylated on serine in vivo, the pattern of phosphorylation of tryptic peptides was the same in unstimulated and stimulated cells, and phosphatase treatment of PDK1 did not affect its in vitro kinase activity.
19. 3for vesicle association than Akt, suggesting that low (possibly basal) levels of 3-phosphoinositides might be sufficient for the membrane localisation of some PDK1.
20. Andjelkovic M., Alessi D.R., Meier R., Fernandez A., Lamb N.J., Frech M., Cron P., Cohen P., Lucocq J.M., Hemmings B.A. Role of translocation in the activation and function of protein kinase B. J Biol Chem. 272:1997;31515-31524. This paper demonstrates that Akt targeted to the plasma membrane by myristoylation or palmitoylation motifs is maximally activated and phosphorylated on Thr308 and Ser473, even when its PH domain is mutated. In addition, overexpressed Akt was shown to translocate to the plasma membrane within 2 minutes of treating 293 cells with IGF-1 and subsequently translocates to the nucleus after 30 minutes.
21. Anderson K.E., Coadwell J., Stephens L.R., Hawkins P.T. Translocation of PDK-1 to the plasma membrane is important in allowing PDK-1 to activate protein kinase B. Curr Biol. 8:1998;684-691. The authors of this paper investigate the role of membrane localisation in PDK1 and Akt activation. Overexpressed PDK1 is shown to translocate to the plasma membrane of PDGF-stimulated cells or cells overexpressing active PI3K where it would co-localize with Akt.
22. Alessi D.R., Kozlowski M.T., Weng Q.P., Morrice N., Avruch J. 3-phosphoinositide-dependent protein kinase 1 (PDK1) phosphorylates and activates the p70 S6 kinase in vivo and in vitro. Curr Biol. 8:1998;69-81.
23. Pullen N., Dennis P.B., Andjelkovic M., Dufner A., Kozma S.C., Hemmings B.A., Thomas G. Phosphorylation and activation of p70s6k by PDK1. Science. 279:1998;707-710.
24. Cheng X., Ma Y., Moore M., Hemmings B.A., Taylor S.S. Phosphorylation and activation of cAMP-dependent protein kinase by phosphoinositide-dependent protein kinase. Proc Natl Acad Sci USA. 95:1998;9849-9854.
25. Le Good J.A., Ziegler W.H., Parekh D.B., Alessi D.R., Cohen P., Parker P.J. Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1. Science. 281:1998;2042-2045.
26. Chou M.M., Hou W., Johnson J., Graham L.K., Lee M.H., Chen C.S., Newton A.C., Schaffhausen B.S., Toker A. Regulation of protein kinase C ζ by PI 3-kinase and PDK-1. Curr Biol. 8:1998;1069-1077.
27. Hawkins P.T., Eguinoa A., Qiu R.G., Stokoe D., Cooke F.T., Walters R., Wennstrom S., Claesson-Welsh L., Evans T., Symons M.et al. PDGF stimulates an increase in GTP-Rac via activation of phosphoinositide 3-kinase. Curr Biol. 5:1995;393-403.
28. 3to the Vav PH domain.
29. Moss J., Vaughan M. Molecules in the ARF orbit. J Biol Chem. 273:1998;21431-21434.
30. Schimmoller F., Itin C., Pfeffer S. Vesicle traffic: get your coat! Curr Biol. 7:1997;235-237.
31. •].
32. •] demonstrate that GRP-1 and cytohesin-1 possess Arf GEF activity, as was suggested by their homology with ARNO, the first Arf GEF cloned from mammals [33].
33. Chardin P., Paris S., Antonny B., Robineau S., Beraud-Dufour S., Jackson C.L., Chabre M. A human exchange factor for ARF contains Sec7- and pleckstrin-homology domains. Nature. 384:1996;481-484.
34. 2. In addition, an ARNO-GFP fusion protein is shown to be cytoplasmic but to rapidly translocate to the plasma membrane upon insulin treatment. This translocation was inhibited by PI3K inhibitors or by co-expression of dominant negative PI3K.
35. 3 in vitro) does not affect PI3K-induced adhesion. This is a good example of the apparent lipid-binding preference of isolated PH domains differing in vitro and in vivo.
36. Salim K., Bottomley M.J., Querfurth E., Zvelebil M.J., Gout I., Scaife R., Margolis R.L., Gigg R., Smith C.I., Driscoll P.C.et al. Distinct specificity in the recognition of phosphoinositides by the pleckstrin homology domains of dynamin and Bruton's tyrosine kinase. EMBO J. 15:1996;6241-6250.
37. Rameh L.E., Arvidsson A., Carraway K.L. Jr., 3rd Couvillon A.D., Rathbun G., Crompton A., VanRenterghem B., Czech M.P., Ravichandran K.S., Burakoff S.J.et al. A comparative analysis of the phosphoinositide binding specificity of pleckstrin homology domains. J Biol Chem. 272:1997;22059-22066.
38. •].
39. •].
40. •] demonstrate that PI3Ks are important in the activation of the tyrosine kinases Btk and Itk, and suggest that Btk and Itk are further activated by Src family tyrosine kinases and serine/threonine kinases.
41. Rhee S.G., Bae Y.S. Regulation of phosphoinositide-specific phospholipase C isozymes. J Biol Chem. 272:1997;15045-15048.
42. •].
43. •].
44. 2+ signalling (for review see [45]).
45. 3: a regulatory nexus between tyrosine kinases and sustained calcium signals. Cell. 94:1998;5-8.
46. Hopkin K. A surprising function for the PTEN tumor suppressor. Science. 282:1998;1027-1030.
47. Myers M.P., Stolarov J.P., Eng C., Li J., Wang S.I., Wigler M.H., Parsons R., Tonks N.K. P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase. Proc Natl Acad Sci USA. 94:1997;9052-9057.
48. 3production.
49. 3but not poly-Glu-phospho-Tyr. In addition, overexpression of wild-type or 'substrate trapping' forms of PTEN is shown to affect 3-phosphoinositide levels and Akt phosphorylation.
50. Stambolic V., Suzuki A., de la Pompa J.L., Brothers G.M., Mirtsos C., Sasaki T., Ruland J., Penninger J.M., Siderovski D.P., Mak T.W. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell. 95:1998;29-39. This paper describes the phenotypes of PTEN knockout mice and fibro- blasts. PTEN knockout mice die in utero by day 9.5 of development and display abnormal patterning and regions of increased proliferation. In contrast, PTEN mutant mouse embryonic fibroblasts show no proliferation defects, but have decreased sensitivity to various apoptotic stimuli and have elevated Akt activity.
51. Haas-Kogan D., Shalev N., Wong M., Mills G., Yount G., Stokoe D. Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC. Curr Biol. 8:1998;1195-1198.
52. 1 and not the induction of apoptosis.
53. 3-binding PH domains and co-expressing PI3K. A variety of PH domains was tested and their in vivo lipid binding-specificity in yeast was shown to reflect well their in vitro lipid binding-specificity. TOPIS was then used to identify several new PH domain-containing proteins that bind 3-phosphoinositides.
54. Bondeva T., Pirola L., Bulgarelli-Leva G., Rubio I., Wetzker R., Wymann M.P. Bifurcation of lipid and protein kinase signals of PI3Kγ to the protein kinases PKB and MAPK. Science. 282:1998;293-296. In vitro, many PI3Ks possess protein kinase activity towards themselves or their associated adaptor subunits. In this report, mutants of the G-protein-linked PI3K p110γ were created which had lost their lipid kinase activity but had retained in vitro protein kinase activity. In a co-expression system, these 'protein kinase only' mutants no longer activate Akt (a 3-phosphoinositide-dependent phenomenon) but do activate the mitogen-activated protein kinase ERK2. Although the physiological relevance of these observations is not entirely clear, these findings do demonstrate that the protein kinase activity of PI3Ks can have an impact on intracellular signal transduction.